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Summary
Estimation of treatment effects in randomized studies is often hampered by possible selection bias 
induced by conditioning on or adjusting for a variable measured post-randomization. One 
approach to obviate such selection bias is to consider inference about treatment effects within 
principal strata, i.e., principal effects. A challenge with this approach is that without strong 
assumptions principal effects are not identifiable from the observable data. In settings where such 
assumptions are dubious, identifiable large sample bounds may be the preferred target of 
inference. In practice these bounds may be wide and not particularly informative. In this work we 
consider whether bounds on principal effects can be improved by adjusting for a categorical 
baseline covariate. Adjusted bounds are considered which are shown to never be wider than the 
unadjusted bounds. Necessary and sufficient conditions are given for which the adjusted bounds 
will be sharper (i.e., narrower) than the unadjusted bounds. The methods are illustrated using data 
from a recent, large study of interventions to prevent mother-to-child transmission of HIV through 
breastfeeding. Using a baseline covariate indicating low birth weight, the estimated adjusted 
bounds for the principal effect of interest are 63% narrower than the estimated unadjusted bounds.
Keywords
Bounds; Causal Effects; Partial Identifiability; Potential Outcomes; Principal Strata
1. Introduction
Often in randomized trials to evaluate the effect of a treatment, inference is hampered by 
possible selection bias induced by conditioning on or adjusting for a variable measured post-
randomization. For instance, in randomized clinical trials where some study participants do 
not comply with their treatment assignment, investigators are often interested in the effect of 
treatment in participants who were compliant. One approach that avoids potential selection 
bias induced by conditioning on a post-randomization variable is to focus inference on the 
causal effect within a principal strata of interest, i.e., the principal effect (Frangakis and 
Rubin 2002). Principal strata are defined by the pair of potential outcomes under either 
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treatment assignment of the post-randomization variable. For instance, in the setting of non-
compliance the principal stratum of interest may be study participants who would comply 
with their randomization assignment regardless of whether assigned to treatment or control 
(Angrist et al. 1996). In vaccine trials, a principal stratum of interest may be individuals who 
would be infected at a certain time regardless of vaccine status (Shepherd et al. 2011). In 
studies of interventions to prevent mother-to-child transmission (MTCT) of HIV through 
breastfeeding, a principal stratum of interest is infants who would be uninfected at a certain 
time regardless of treatment (Nolen and Hudgens 2011; Long and Hudgens 2012). There are 
many other settings where inference about treatment effects within certain principal strata 
may be of interest; see VanderWeele (2011) for a recent overview. A primary goal in these 
settings is often to better understand a treatment’s effect by drawing inference about effects 
within subgroups defined by the principal strata. The principal stratification approach is less 
helpful for decision making, as principal stratum membership is generally not identifiable 
prior to treatment (Joffe 2011).
In many instances, even after treatment assignment individual principal strata membership is 
not identifiable from the observable data without strong assumptions because only one of the 
two post-randomization variable potential outcomes is ever observed for an individual. In 
turn, the principal effect of interest is not identifiable. One approach to cope with lack of 
identifiability is to conduct sensitivity analysis wherein some model is assumed, indexed by 
an unidentifiable parameter conditional on which the principal effect is identifiable from the 
observable data. Inference about the principal effect is then conducted conditional on some 
value of the unidentifiable parameter and sensitivity of the inference is examined by 
considering different values of the parameter. An alternative approach entails drawing 
inference about bounds on the principal effects, e.g., Zhang and Rubin (2003), Cheng and 
Small (2006). Informally, these extreme bounds provide the smallest and largest possible 
values of the principal effect consistent with the observed data distribution. This approach is 
appealing in that typically bounds can be obtained under minimal assumptions. However, in 
many cases the bounds may be quite wide and therefore not particularly informative about 
the principal effect.
Grilli and Mealli (2008) derived nonparametric bounds on principal effects under a number 
of different assumptions. They suggested these bounds can be improved (or narrowed) by 
creating bounds within strata defined by a baseline covariate and combining these stratum 
specific bounds by taking a weighted average to obtain new adjusted bounds on the 
principal effect. Grilli and Mealli employed this approach in the analysis of data from an 
employment study with mixed results: the adjusted bounds were an improvement on only 
one side of the unadjusted bounds, i.e., the adjusted upper bound was less than the 
unadjusted upper bound but the adjusted lower bound was also less than the unadjusted 
lower bound. The reason for only partial improvement was not addressed. More recent work 
by Lee (2009) and Mealli and Pacini (2012) indicate the adjusted bounds will never be wider 
than the unadjusted bounds and sometimes the adjusted bounds will be strictly narrower than 
the unadjusted bounds. In this paper we characterize the exact circumstances for which 
adjusting for a baseline covariate leads to improved bounds.
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The outline of the remainder of this paper is as follows. In Section 2, notation and 
assumptions are introduced. Section 3 explains the lack of identifiability of the principal 
effect and in Section 4 the unadjusted bounds are reviewed. Section 5 defines the adjusted 
bounds based on a weighted average of bounds within levels of the baseline covariate. 
Section 6 contains the main result of this paper, giving necessary and sufficient conditions 
under which the covariate adjusted bounds improve upon (i.e., are narrower than) the 
unadjusted bounds. In Section 7 large sample inferential methods are discussed. In Section 
8, the adjusted and unadjusted bounds are compared using data from a recent, large MTCT 
study. Conditions in which adjusting for the covariate leads to identification of the principal 
effect are discussed in Section 9. A brief discussion is given in Section 10. Proofs of the 
propositions in Section 6 are given in the Web Appendix A.
2. Notation and Assumptions
To motivate, throughout we consider the MTCT example where infants of HIV positive 
mothers are randomized at birth (i.e., baseline or time 0) to treatment or control. Suppose n 
infants are enrolled in a MTCT study and for i = 1, …, n let Zi denote the randomization 
assignment for infant i. Without loss of generality let Zi = 0 correspond to control and Zi = 1 
correspond to treatment. Let Xi be some binary variable measured at baseline (prior to 
randomization) taking on values 0 or 1. For simplicity Xi is assumed to be binary for now, 
although the results derived below will apply for any baseline categorical covariate with a 
finite number of levels. The primary endpoint in MTCT studies is typically HIV infection of 
the infant by some time point τ (e.g., six months) after baseline. Denote the presence or 
absence of the primary endpoint by Yi, where Yi = 1 indicates infant i became infected by τ 
and otherwise Yi = 0. Because the goal of treatment is to prevent breast milk transmission of 
HIV, investigators are primarily interested in infant HIV infections that occur before τ but 
after some time τ0 > 0 (e.g., τ0 = 2 weeks), as infections prior to τ0 are likely due to in utero 
or peripartum transmission and not breastfeeding. Let Si denote whether infant i is infected 
by τ0, where Si = 1 if infant i is HIV infected by τ0 and Si = 0 otherwise. Let Si(z) denote the 
potential value of Si when assigned treatment z for z = 0, 1 such that Si = (1 − Zi)Si(0) + 
ZiSi(1). Define Yi(z) similarly. Assume the treatment assignment of an infant does not affect 
the potential outcomes of other infants (i.e., there is no interference) and that there are not 
multiple forms of treatment.
An analysis of the effect of treatment that simply excludes infants infected by τ0 (i.e., Si = 1) 
is subject to selection bias. That is, because the set (or population) of infants that would be 
infected by τ0 when assigned treatment Zi = 1 is not necessarily the same as the set of infants 
that would be infected by τ0 if assigned control Zi = 0, direct comparisons between trial 
arms that exclude infants infected by τ0 in general do not have a causal interpretation. To 
avoid such selection bias, the principal stratification framework may be adopted (Frangakis 
and Rubin 2002). Principal strata are defined by sets of infants with the same potential 
outcome pair (Si(0) = s0, Si(1) = s1). Define the always infected (AI) principal stratum to be 
infants with s0 = s1 = 1, i.e., infants who would be infected at τ0 regardless of randomization 
assignment. Similarly define the harmed stratum as those infants with s0 = 0, s1 = 1; the 
protected stratum as those infants with s0 = 1, s1 = 0; and the never infected (NI) stratum as 
those infants with s0 = s1 = 0. Based on considerations described above, investigators 
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conducting MTCT trials are interested in the NI stratum. The causal estimand of interest, the 
principal effect, is the effect of treatment on Yi in infants who would be uninfected at τ0 
under either randomization assignment, namely
Below we consider large sample bounds for CE that do and do not adjust for the baseline 
covariate Xi. Throughout we assume
Assumption 1 (Independent Treatment Assignment): Zi ⊥ (Xi, Si(0), Si(1), Yi(0), Yi(1))
Assumption 2 (Monotonicity): Si(1) ≤ Si(0) for all i
where ⊥ denotes independence. Assumption 1 will hold in randomized trials. Monotonicity 
assumes that treatment does no harm with respect to the intermediate variable Si, i.e., there 
are no infants who would be infected by τ0 only if treated. Under Assumption 2, there are 
only three possible principal strata: AI, NI, and protected.
3. Partial Identifiability
In this section we consider identifiability of CE. Let θzst = Pr[Yi(z) = 1|Si(1) = s, Si(0) = t], πz 
= Pr[Yi(z) = 1|Si(z) = 0], and γ = Pr[Si(0) = 0|Si(1) = 0], such that CE = θ100 − θ000. Assume 
γ > 0 as otherwise the NI stratum is empty with probability 1. Under Assumptions 1 and 2, 
θ000 = Pr[Yi = 1|Si = 0, Zi = 0], which is identifiable from the observed data. However, θ100 
is not identifiable. Following Hudgens and Halloran (2006) note
i.e.,
(1)
Under Assumption 1, π1 is identifiable. Under Assumptions 1 and 2, γ is identifiable 
because
On the other hand, θ100 and θ101 are not identifiable because infants who were assigned 
treatment and uninfected at τ0 are a mixture of infants from the protected and NI strata. 
Solving (1) for θ100 yields
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(2)
Equation (2) describes a line with intercept π1/γ and slope −(1 − γ)/γ. Any pair of points 
(θ101, θ100) in the unit square that are on this line will give rise to the same observed data 
distribution.
Note that CE is identifiable if and only if γ = 1, π1 = 1, or π1 = 0. If γ = 1, then (2) is a 
horizontal line with intercept π1 and thus θ100 = π1. Note γ = 1 is equivalent to Pr[Si(0) = 0] 
= Pr[Si(1) = 0], i.e., treatment has no effect on the intermediate variable Si. If π1 = 1, then (1) 
implies θ100 = 1; geometrically this corresponds to the line (2) intersecting the unit square at 
the upper right corner (1,1). In words, π1 = 1 means that all treated infants who are 
uninfected at τ0 will become infected by τ. Likewise, if π1 = 0, then (1) implies θ100 = 0, 
corresponding to the line (2) intersecting the unit square at the origin (0,0). In words, π1 = 0 
means that all treated infants who are uninfected at τ0 will not become infected by τ. 
Otherwise, if γ < 1 and 0 < π1 < 1, under Assumptions 1 and 2, CE is not identifiable from 
the observable random variables. On the other hand, θ000, π1, and γ are identifiable, 
implying the observed data distribution does reveal some information about possible values 
for CE, i.e., CE is partially identifiable. The focus of the sequel is on large sample bounds, 
i.e., the smallest and largest possible values of CE that are consistent with the observed data 
law.
4. Unadjusted Bounds
In this section, we present large sample bounds for CE (Zhang and Rubin 2003; Hudgens et 
al. 2003) that ignore the baseline covariate X. The large sample bounds for CE are found by 
first bounding θ100. The upper bound for θ100 is obtained by assuming θ101 = 0 or θ100 = 1. 
Likewise, the lower bound for θ100 is obtained by assuming θ101 = 1 or θ100 = 0. These 
bounds can be envisaged as corresponding to the points where the line (2) intersects the unit 
square (Hudgens and Halloran 2006). In particular, the upper and lower bounds are
(3)
Bounds for CE are found by replacing θ100 by  and , i.e.,  and 
. These bounds will be referred to as “unadjusted” bounds because no 
information from the covariate is used.
To illustrate, let the probabilities corresponding to a fictitious trial of MTCT of HIV be γ = 
0.95, π1 = 0.02, and π0 = 0.05. Using (3), for this trial 
 and  (note here 
and in the sequel that reported numerical results are rounded, in this case to the third decimal 
place). This gives the unadjusted bounds as [CEl, CEu] = [0–0.05, 0.021–0.05] = [−0.05, 
−0.029] because θ000 = π0. In this example the bounds exclude zero, implying treatment 
reduces the risk of Y = 1 in the NI stratum. Let the probabilities for a second fictitious trial 
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be γ = 0.80, π1 = 0.85, and π0 = 0.95. Then  and , implying the unadjusted 
bounds are [CEl, CEu] = [−0.137, 0.05]. These two fictitious trials will be revisited in the 
next section.
5. Adjusted Bounds
Next we consider the method proposed by Grilli and Mealli (2008) for adjusting the large 
sample bounds using the binary baseline covariate X, i.e., bounds will be obtained within 
strata defined by X and then weighted averages of the stratum specific bounds will be 
computed. Let θzstx = Pr[Yi(z) = 1|Si(1) = s, Si(0) = t, Xi = x], γx = Pr[Si(0) = 0|Si(1) = 0, Xi = 
x], πzx = Pr[Yi(z) = 1|Si(1) = 0, Xi = x], ϕx = Pr[Xi = x|Si(1) = Si(0) = 0], and λx = Pr[Xi = x|
Si(1) = 0]. Throughout it is assumed that Pr[Si(1) = 0, Si(0) = t, Xi = x] > 0 for x, t = 0, 1 such 
that the conditional probabilities θz0tx, γx, and πzx are all well defined. This assumption also 
implies γx > 0, ϕx > 0 and λx > 0 for x = 0, 1. Note
(4)
where here and in the sequel . As in the unadjusted case, θ100x is not 
identifiable but using arguments analogous to (2) for Xi = x
(5)
and identifiable upper and lower bounds for θ100x are
(6)
Under Assumptions 1 and 2, ϕx is identifiable because Pr[Xi = x|Zi = 0, Si = 0] = Pr[Xi = x|
Si(0) = 0] = Pr[Xi = x|Si(1) = Si(0) = 0]. Therefore, identifiable bounds for θ100 can be 
obtained by combining (4) and (6), namely
(7)
This leads to adjusted bounds  and .
Table 1 contains the values of two different binary baseline covariates, X1 and X2, for each 
of the fictional trials discussed in Section 4. For the first trial and X1, by (6) we have 
, and . Thus,  and . 
Therefore, there is improvement to the lower bound of CE but not to the upper bound when 
adjusting for X1, and thus the unadjusted bounds [CEl, CEu] = [−0.05, −0.029] are wider 
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than the adjusted bounds . On the other hand, adjusting by 
X2 in the first trial does not yield an improvement since  and 
.
For the second trial and X1, , and . Thus, 
 and . Here adjusting for X1 yields a smaller upper bound resulting 
in narrower bounds, i.e., [CEl, CEu] = [−0.137, 0.05] to . 
Moreover, the adjusted upper bound is less than the null value of 0, indicating treatment has 
an effect in the NI principal stratum; such a conclusion was not possible prior to adjusting 
for X1. On the other hand, adjusting for X2 in the second trial yields no improvement in the 
bounds because  and .
A graphical depiction of the unadjusted and adjusted bounds is given in Figure 1. The 
unadjusted bounds correspond to where the solid lines intersect the unit square. Bounds 
within strata defined by X correspond to where the dashed and dotted lines intersect the unit 
square. The adjusted bounds, represented by ○ and +, are weighted averages of these 
stratum specific bounds. For example, in the upper left panel corresponding to trial 1 and X1, 
we see that  is greater than  because the vertical value of + is greater than zero, the 
point where the solid line intersects the horizontal axis.
6. Improvement of the Bounds
The examples in the preceding section illustrate that adjusting for a baseline covariate may 
or may not improve the bounds on CE. In this section, we give necessary and sufficient 
conditions for when the adjusted bounds (7) will be narrower than the unadjusted bounds of 
(3). Proofs of all propositions are given in Web Appendix A.
Proposition 1
 for any baseline binary covariate X.
According to Proposition 1, the adjusted bounds will be at least as narrow as the unadjusted 
bounds no matter the choice of X. This proposition is analogous to Proposition 1b of Lee 
(2009) for Y continuous. To characterize the conditions under which the adjusted bounds are 
strictly narrower than the unadjusted bounds, consider the following two criteria:
(8)
and
(9)
where the value of x in (8) and (9) is not necessarily the same. In words, (8) and (9) indicate 
that Xi is informative about particular orderings between (i) the distribution of Si(0) given 
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Si(1) = 0 and (ii) the distribution of Yi(1) given Si(1) = 0. For the motivating example, these 
criteria indicate that the ordering of (i) the risk of infection (or not) by τ0 when not treated 
and (ii) the risk of infection by τ when treated is different between strata defined by the 
levels of Xi among infants who would not be infected by τ0 if treated. On the other hand, if 
Xi is uninformative about the relation between (i) and (ii) then neither (8) nor (9) will hold. 
For example, if Xi is independent of Si(0) given Si(1) = 0 and if Xi is independent of Yi(1) 
given Si(1) = 0, then neither (8) nor (9) will hold. Using (8) and (9), the following 
propositions characterize exactly the situations when the adjusted bounds will be narrower.
Proposition 2
 if and only if X satisfies (8).
Proposition 2 states (8) is a necessary and sufficient condition for the adjusted upper bound 
for θ100 to be less than the unadjusted bound. This proposition is exemplified in the second 
fictional trial from Section 5 using X1, where π10 < γ0 and π11 > γ1. As shown in the lower 
left panel of Figure 1, (8) is satisfied because the dashed line has intercept greater than 1 and 
the dotted line has intercept less than 1. In contrast, for X1 in the first fictional trial (8) is not 
satisfied because the dashed and dotted lines in the upper left panel of Figure 1 both have 
intercepts less than 1; thus the adjusted upper bound based on X1 does not improve upon the 
unadjusted upper bound.
Proposition 3
 if and only if X satisfies (9).
Proposition 3 provides a necessary and sufficient condition for the adjusted lower bound to 
be greater than the unadjusted lower bound. This proposition is illustrated in the first 
fictional trial from Section 5 using X1, where π10 > (1 − γ0) and π11 < (1 − γ1). As shown in 
the upper left panel of Figure 1, (9) is satisfied because the dashed line intersects the bottom 
of the unit square whereas the dotted line intersects the right side of the unit square. In 
contrast, for X1 in the second ficitious trial (9) is not satisfied because the dashed and dotted 
lines in the lower left panel of Figure 1 both intersect the right side of the unit square; thus 
the adjusted lower bound equals the unadjusted lower bound.
Additional insight regarding criteria (8) and (9) can be obtained by constructing principal 
strata based on cross-classification of {Si(0), Si(1)} as well as {Yi(0), Yi(1)}. Further details 
regarding this approach are given in Web Appendix B.
It follows immediately from Propositions 2 and 3 that if (8) and (9) both hold then the 
adjusted bounds are strictly contained within the unadjusted bounds and if neither hold, the 
adjusted and unadjusted bounds are equal. Note while it was assumed that X was a binary 
covariate, Propositions 1–3 can immediately be extended to any categorical baseline 
covariate with a finite number of levels k. Specifically, suppose adjusted bounds are 
calculated within each of the k strata and weighted averages of these bounds are computed 
analogous to (7). Then Proposition 1 will hold, and if there exists any two levels of X that 
satisfy either (8) or (9), then either Proposition 2 or Proposition 3 will hold respectively.
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7. Inference
The unadjusted and adjusted bounds can be consistently estimated by plugging in consistent 
estimators of the component parameters of the bounds. Specifically, let
and
where  and I() is the usual indicator function. Likewise, let ϕ̂x = Σ(1 − Si)(1 − 
Zi)I(Xi = x)/Σ(1 − Si)(1 − Zi), π̂z = ΣYi(1 − Si)I(Zi = z)/Σ(1 − Si)I(Zi = z), and π̂zx = ΣYi(1 − 
Si)I(Zi = z, Xi = x)/Σ(1 − Si)I(Zi = z, Xi = x). In the data example presented in Section 8 
below, individuals drop out of the study prior to evaluation of Yi so that the simple moment 
estimators π̂z and π̂zx given above will not be possible to compute. We ignore this 
complication for now and will return to this issue below.
Consistent estimators of the unadjusted bounds are  and 
where  and  are obtained by plugging in π̂1 and γ̂ into (3) and θ̂000 = π̂0. Similarly, 
letting  and  denote (6) evaluated at π̂1x and γ̂x, consistent estimators of the 
unadjusted bounds are  and  where  and  are 
obtained by plugging in ϕ̂x, , and  into (7).
These estimated bounds reflect ignorance due to partial identifiability but do not account for 
uncertainty due to sampling variability; such uncertainty intervals can be constructed using 
the approach of Imbens and Manski (2004) and Vansteelandt et al. (2006). In particular, Lee 
(2009) proved the estimated unadjusted bounds  and  are asymptotically normal 
under standard regularity conditions and provided that Pr[Si(1) < Si(0)] > 0, i.e., treatment 
has a protective effect on the intermediate variable Si. Under these conditions, a (1 − α) × 
100% pointwise uncertainty interval for CE is given by
(10)
where  can be computed using equation (4.3) of Vansteelandt et al. (2006), and 
 and  are consistent estimators of  and . As n → ∞, 
the interval (10) will contain CE with probability (1 −α). A pointwise uncertainty interval 
based on the estimated adjusted bounds can be constructed analogously.
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8. Illustration
The Breastfeeding, Antiretroviral, and Nutrition (BAN) study was a randomized clinical trial 
to assess interventions for the prevention of breast milk transmission of HIV in 2369 HIV 
infected mothers and their infants in Lilongwe, Malawi (Chasela et al. 2010). There were 
three arms in the BAN study: daily antiretroviral therapy (ART) for the infant, daily ART 
for the mother, or control. While the primary analysis of the study considered comparisons 
of both ART arms to control, we will focus on comparing the infant ART and control arms 
only. The primary endpoint of BAN was infant HIV infection by τ = 28 weeks, so we let Yi 
= 1 if the infant was HIV positive by 28 weeks and Yi = 0 otherwise. Per protocol, infants 
who died or were infected in the first two weeks post-treatment were to be excluded from 
the primary analysis. Let Si = 1 if the infant became HIV positive or died by τ0 = 2 weeks, Si 
= 0 otherwise. An analysis that compares randomization groups conditional on Si = 0 is 
subject to selection bias. Instead we let the target of inference be CE, the change in risk of 
infection by 28 weeks due to infant ART in infants who would be HIV negative and alive at 
two weeks regardless of randomization assignment. Below estimated unadjusted bounds for 
CE are compared with estimated adjusted bounds based on a binary variable Xi indicating 
low birth weight (< 2.5 kg), i.e., Xi = 1 if the infant was of low birth weight, 0 otherwise.
Table 2 presents data on S and X from BAN by randomization arm. The proportion of 
infants who die or become HIV infected by two weeks is somewhat higher in the control 
group (5.7% versus 4.6%), although the difference is not statistically significant (Fisher’s 
exact test two-sided p = 0.35). That the proportion was higher in the control group supports 
the monotonicity assumption. Because some mother-infant pairs dropped out of the study 
prior to 28 weeks, the simple moment estimators of πz and πzx given in Section 7 cannot be 
computed. In the absence of competing risks and informative censoring, πx and πzx can be 
consistently estimated using the Kalpan-Meier estimator. However, in the BAN study death 
and breastfeeding cessation prior to HIV infection were competing risks. Therefore the 
Aalen-Johansen estimator (Aalen and Johansen 1978) for the cumulative incidence function 
can be used to estimate πz and πzx; see Long and Hudgens (2012) for additional details. The 
Aalen-Johansen estimates (ignoring X) were π̂0 = 0.0581 and π̂1 = 0.0141. Using these 
estimates, the estimated unadjusted lower and upper bounds of CE are 
. Stratifying by X, the Aalen-Johansen estimators for each 
randomization arm were π̂00 = 0.0609, π̂01 = 0.0233, π̂10 = 0.0107, and π̂11 = 0.0604. 
Therefore the estimated adjusted lower and upper bounds are 
.
In this example, the estimated adjusted lower bound is greater than the estimated unadjusted 
lower bound, which is expected based on Proposition 3 and the fact Xi satisfies (9) 
empirically, i.e., π̂10 > (1 − γ̂0) and π̂11 < (1 − γ̂1). On the other hand, the estimated adjusted 
upper bound is greater than the estimated unadjusted upper bound, empirically contradicting 
Proposition 1. That the estimated adjusted upper bound is not less than the estimated 
unadjusted upper bound is actually not surprising based on Proposition 2 and the fact Xi does 
not satisfy (8) empirically, in particular π̂1x < γ̂x for x = 0, 1. This suggests the adjusted and 
unadjusted upper bounds are equal, in which case no particular ordering between the 
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adjusted and unadjusted estimators might be expected. Grilli and Mealli (2008) reported a 
similar finding in an analysis of employment data of university students. This apparent 
contradiction between the estimated bounds and Proposition 1 suggests alternative adjusted 
estimators of the bounds, namely  and . 
These estimators are consistent for  and  and by construction will always 
empirically satisfy Proposition 1, i.e., will always be at least as narrow as the estimated 
unadjusted bounds. For the BAN data, . That is, by 
adjusting for the baseline covariate X indicating lower birth weight, the estimated bounds on 
CE are 63% narrower than the estimated unadjusted bounds.
Uncertainty intervals corresponding to the estimated unadjusted and adjusted bounds were 
computed using (10) with bootstrap variance estimates (as in Long and Hudgens 2012). For 
the unadjusted bounds, the estimated 95% pointwise uncertainty interval equals [−0.076, 
−0.025]. Corresponding to the estimated adjusted bounds [ ] based on the low 
birth weight indicator, the estimated 95% pointwise uncertainty interval equals [−0.069, 
−0.024], i.e., adjusting for low birth weight also results in a narrower estimated uncertainty 
interval.
9. Identifiability
As noted at the end of Section 3, in the absence of covariate X, CE is identifiable if and only 
if one of the following three conditions occur: γ = 1, π1 = 1, or π0 = 0. When at least one of 
these conditions holds, CE is identifiable and , i.e., the bounds collapse to a single 
point. In this section we consider conditions under which adjusting for the binary covariate 
X renders CE identifiable in the sense that the adjusted bounds collapse to a point, i.e., 
. By the form of the adjusted bounds given in (7) and the assumption ϕx > 0 for 
x = 0, 1, it follows that the adjusted bounds yield a single point if and only if
(11)
for x = 0 and x = 1.
Ding et al. (2011) also considered identifiability of a principal effect when outcomes are 
truncated by death, which is mathematically identical to the problem considered here. In 
addition to Assumptions 1 and 2 above, Ding et al. provided two additional assumptions 
which are sufficient for identifiability: (i) Xi ⊥ Yi|{Si(0), Si(1), Zi} and (ii) Pr[Xi = x|Si(0) = 
Si(1) = 0] ≠ Pr[Xi = x|Si(0) = 1, Si(1) = 0]. Unfortunately, assumption (i), which under 
Assumption 1 can be equivalently stated as Xi ⊥ Yi(z)|{Si(0), Si(1)} for z = 0, 1, is in general 
not subject to empirical test based on the observable data. Ding et al. also gave sufficient 
identifiability conditions that do not require (i) but instead require that X takes on at least 
three levels or is continuous and that the mean of Y satisfies a particular linear model.
In contrast, condition (11) can be assessed from the observable data because γx and π1x are 
identifiable under Assumptions 1 and 2 only. Moreover, (11) suggests a strategy for 
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selecting X. In particular, if a covariate X can be found such that (11) holds for x = 0, 1, then 
CE will be identifiable. If no such covariate is available, then selecting X such that (11) 
approximately holds for x = 0, 1 should yield adjusted bounds with width close to zero. For 
instance, in the MTCT from the previous section, the low birth weight indicator covariate X 
yields γ̂0 = 1.000, i.e., (11) empirically holds for x = 0; while (11) does not hold empirically 
for x = 1, π̂11 = 0.0604 is not too far from zero and indeed the birth weight adjusted bounds 
for CE are substantially narrower than the unadjusted bounds.
Finally, we note two special cases where Xi identifies CE. First, suppose Xi = 1 if and only if 
Si(0) = Si(1) = 0, i.e., Xi is a perfect predictor of membership in the NI principal stratum. 
Then trivially CE is identifiable under Assumption 1 alone by the stratum of individuals 
with Xi = 1. This first case is related to the “principal score,” i.e., the probability an 
individual is within a principal stratum conditional on one or more covariates (Jo and Stuart, 
2009). In practice, principal scores are not known but predicted based on fitted models using 
the observed data. For example, in the MTCT setting a model for Pr[Si(0) = Si(1) = 0|Xi = x] 
can be fit using data from infants assigned Zi = 0 because under Assumptions 1 and 2 such 
infants are in the NI stratum if and only if Si = 0. If a set of one or more baseline covariates 
(not necessarily binary or even discrete) can be found such that the principal scores for the 
NI stratum equal zero or one for each individual, then CE is identified by the stratum of 
individuals with principal scores equal to one. In practice this may not be possible; however, 
if covariates can be found such that the principal scores for the NI stratum are all close to 
zero or one, i.e., the principal scores are highly predictive of NI stratum membership, then 
the adjusted bounds constructed by stratifying on a dichotomization of the principal score 
should have width near zero. For the second special case, suppose Yi = 1 if and only if Xi = 
1, i.e., Xi is a perfect predictor of Yi. Then π10 = 0 and π11 = 1 implying (11) holds for x = 0 
and x = 1 and therefore . In settings where Zi has an effect on Yi and Zi is 
assigned randomly, no such perfect predictor Xi will exist (because Xi is measured pre-
randomization), such that the second case seems to have little practical implication.
10. Discussion
In this paper we considered whether bounds on principal effects can be improved by 
adjusting for a categorical baseline covariate. Necessary and sufficient conditions were 
derived for which the covariate adjusted bounds will be sharper (i.e., narrower) than the 
unadjusted bounds. The methods were illustrated using data from a study of interventions to 
prevent mother-to-child transmission of HIV through breastfeeding. Using a baseline 
covariate indicating low birth weight, the estimated adjusted bounds for the principal effect 
of interest were 63% narrower than the estimated unadjusted bounds.
The veracity of the analysis of the BAN trial depends on several key assumptions. 
Assumption 1, independent treatment assignment, is reasonable because infants were 
randomly assigned treatment. Assumption 2, monotonicity, implies that the treatment is no 
worse than control for any individual in terms of the intermediate variable S. As mentioned 
in Section 8 this assumption is supported by the observed data. Additionally, the BAN study 
principal investigator, Dr. Charles van der Horst, has indicated that monotonicity is 
reasonable (personal communication). However, in other settings this assumption may be 
Long and Hudgens Page 12
Biometrics. Author manuscript; available in PMC 2014 July 08.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
unrealistic. For example, monotonicity might be considered questionable in an analysis 
comparing the two active arms of the BAN trial, i.e., infant ART versus maternal ART. In 
such settings, bounds that do not require the monotonicity assumption would be needed.
There are several possible avenues of related future research. One possible direction entails 
studying how adjusting for covariates affects the efficiency with which the bounds are 
estimated. For example, is it possible that certain covariates could be advantageous to adjust 
for with respect to sharpening bounds, but disadvantageous to adjust for in terms of 
efficiency? In the presence of multiple baseline covariates, future research could explore a 
formal approach for determining which covariates to adjust for (or include in a principal 
score model) and how to subsequently draw valid inference accounting for the covariate 
selection process. Related to Assumption 2, future research could examine relations between 
adjusted and unadjusted bounds when monotonicity is assumed for the primary endpoint Y.
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Figure 1. 
Graphical depiction of bounds for the two fictional MTCT trials discussed in Section 5 with 
two different binary covariates X1 and X2. The solid lines depict equation (2) with π1 = 0.02 
and γ = 0.95 in the upper panels and π1 = 0.85 and γ = 0.8 in the lower panels. The · · · (– – 
–) lines represent (5) for X = 0 (X = 1). The vertical value of ○ (+) corresponds to 
.
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Table 1
Probabilities from the fictional trials described in Section 4 stratified by X1 and X2.
Trial 1 X1 X2
0 1 0 1
 γx 0.995 0.920 0.980 0.880
 π1x 0.035 0.010 0.005 0.055
 λx 0.400 0.600 0.700 0.300
 ϕx 0.419 0.581 0.722 0.278
Trial 2 X1 X2
0 1 0 1
 γx 0.890 0.740 0.875 0.625
 π1x 0.760 0.910 0.910 0.710
 λx 0.400 0.600 0.700 0.300
 ϕx 0.445 0.555 0.766 0.234
Note by Bayes Theorem ϕx must equal γxλx/(γ0λ0 + γ1λ1) for x = 0, 1; values of ϕx reported in the table have been rounded.
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